Erschienen in:
01.08.2013 | LETTER TO THE EDITOR
Nitroglycerin does not Interfere with Protection by Remote Ischemic Preconditioning in Patients with Surgical Coronary Revascularization under Isoflurane Anesthesia
verfasst von:
Petra Kleinbongard, Matthias Thielmann, Heinz Jakob, Jürgen Peters, Gerd Heusch, Eva Kottenberg
Erschienen in:
Cardiovascular Drugs and Therapy
|
Ausgabe 4/2013
Einloggen, um Zugang zu erhalten
Excerpt
Remote ischemic preconditioning (RIPC) of the myocardium by repeated brief limb ischemia/reperfusion reduces damage from myocardial ischemia/reperfusion. Such protection strategy has been successfully translated from the experiment to clinical use [
1‐
3]. However, the transfer of the protective signal from the ischemic/reperfused limb to the heart remains unknown. Endogenous nitric oxide (NO) is a potential trigger and mediator of pre- and postconditioning [
4]. Exogenous NO prior to ischemia attenuates the consequences of myocardial ischemia/reperfusion [
5,
6]. Nitroglycerin is a NO releasing drug and used to reduce preload and consequently cardiac output and blood pressure in various clinical settings, including coronary artery bypass graft (CABG) surgery. …